Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 246

1.

Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.

Suzuki H, Shimada Y, Fujiwara K.

Ther Adv Cardiovasc Dis. 2012 Dec;6(6):237-44. doi: 10.1177/1753944712464285. Epub 2012 Nov 5.

PMID:
23129531
[PubMed - indexed for MEDLINE]
2.

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.

Mengden T, Uen S, Bramlage P.

Vasc Health Risk Manag. 2009;5:1043-58. Epub 2009 Dec 29. Review.

PMID:
20057897
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.

Racine N, Hamet P, Sampalis JS, Longo N, Bastien N.

J Hum Hypertens. 2010 Nov;24(11):739-48. doi: 10.1038/jhh.2010.3. Epub 2010 Feb 11.

PMID:
20147971
[PubMed - indexed for MEDLINE]
4.

Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.

Meno H, Inou T, Tanaka M, Tsuchiya Y, Shiga Y, Kobayashi K, Nakamura Y, Ota T, Kubara I.

Arzneimittelforschung. 2012 Sep;62(9):414-9. doi: 10.1055/s-0032-1316376. Epub 2012 Jul 6.

PMID:
22773432
[PubMed - indexed for MEDLINE]
5.

Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice.

Schmieder RE, Schwertfeger M, Bramlage P.

Vasc Health Risk Manag. 2009;5:991-1000. Epub 2009 Nov 16.

PMID:
19997579
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.

Toh R, Ishida T, Nishimura K, Nonaka H, Inoue Y, Kitagawa Y, Suematsu M, Miki T, Emoto N, Hirata K.

Hypertens Res. 2012 Nov;35(11):1080-6. doi: 10.1038/hr.2012.110. Epub 2012 Jul 12.

PMID:
22786569
[PubMed - indexed for MEDLINE]
7.

Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.

Kim KS, Fan WH, Kim YD, Zhu W, Ngau YY, Tong P, Kim BS, Santos M, Lin WH, Buranakitjaroen P, Massaad R, Smith RD; Asia HEAALTH Study Investigators.

Hypertens Res. 2009 Jun;32(6):520-6. doi: 10.1038/hr.2009.42. Epub 2009 Apr 24.

PMID:
19390542
[PubMed - indexed for MEDLINE]
8.

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.

Barrios V, Escobar C, Calderon A, Böhm M.

Vasc Health Risk Manag. 2009;5:723-9. Epub 2009 Sep 7.

PMID:
19756164
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).

Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.

Adv Ther. 2010 Jun;27(6):365-80. doi: 10.1007/s12325-010-0032-7. Epub 2010 Jun 16.

PMID:
20556561
[PubMed - indexed for MEDLINE]
10.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
[PubMed - indexed for MEDLINE]
11.

Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.

Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T; COMFORT Investigators.

Circ J. 2012;76(6):1415-22. Epub 2012 Mar 15.

PMID:
22447014
[PubMed - indexed for MEDLINE]
Free Article
12.

Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.

Shimosawa T, Gohchi K, Yatomi Y, Fujita T.

Hypertens Res. 2007 Sep;30(9):831-7.

PMID:
18037776
[PubMed - indexed for MEDLINE]
13.

Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy.

Weinberger MH, Glazer RD, Crikelair NA, Chiang YT.

J Hum Hypertens. 2010 Dec;24(12):823-30. doi: 10.1038/jhh.2010.17. Epub 2010 Feb 25.

PMID:
20182456
[PubMed - indexed for MEDLINE]
14.

Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

Keating GM.

Drugs. 2009 Jun 18;69(9):1239-65. doi: 10.2165/00003495-200969090-00008. Review.

PMID:
19537840
[PubMed - indexed for MEDLINE]
15.

The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.

Pool JL, Glazer R, Crikelair N, Levy D.

Clin Drug Investig. 2009;29(12):791-802. doi: 10.2165/11530600-000000000-00000.

PMID:
19888785
[PubMed - indexed for MEDLINE]
16.

Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.

Everett BM, Glynn RJ, Danielson E, Ridker PM; Val-MARC Investigators.

Clin Ther. 2008 Apr;30(4):661-72.

PMID:
18498915
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of losartan 100 mg or losartan 100 mg plus hydrochlorothiazide 25 mg in the treatment of patients with essential arterial hypertension and CV risk factors: observational, prospective study in primary care.

Bönner G, Smolka W, Jung C, Bestehorn K.

Curr Med Res Opin. 2009 Apr;25(4):981-90. doi: 10.1185/03007990902809876 .

PMID:
19254206
[PubMed - indexed for MEDLINE]
18.

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.

Bramlage P.

Vasc Health Risk Manag. 2009;5(1):213-24. Epub 2009 Apr 8. Review.

PMID:
19436667
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.

Abe M, Okada K, Matsumoto K.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1285-303. doi: 10.1517/17425250903282799. Review.

PMID:
19761411
[PubMed - indexed for MEDLINE]
20.

Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.

Sica D, Gradman AH, Lederballe O, Kolloch RE, Zhang J, Keefe DL.

Clin Drug Investig. 2011 Dec 1;31(12):825-37. doi: 10.2165/11590280-000000000-00000.

PMID:
22035463
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk